COMP <GO>
ELV vs NTRA // EV/EBITDA & P/E VALUATION
Elevance Health Inc. (NYSE) VS. Natera Inc. (NASDAQ) • 15-METRIC TALLY: ELV 7
— NTRA 4
■ METRIC PARITY
LAST: $420.07 (-0.46%) • MKT CAP: $91.18B
valuation
13.8x
LAST: $414.30 (-4.98%) • MKT CAP: $62.85B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ELV VS. NTRA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ELV | NTRA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 89.40% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.70% | -4.90% | +13.60 | ELV | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 13.8x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 3.48% | 0.17% | +3.31 | ELV | /fcf-yield <GO> |
| Operating Margin | 3.60% | -13.40% | +17.00 | ELV | /operating-margins <GO> |
| Net Profit Margin | 2.80% | -9.00% | +11.80 | ELV | /net-margins <GO> |
| Revenue Growth (YoY) | 12.50% | 35.90% | -23.40 | NTRA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.68% | 0.00% | +1.68 | ELV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.17 | 26.00 | -22.83 | NTRA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.0 | 64.0 | -12.00 | NTRA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.07 | 1.09 | -0.02 | NTRA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 13.5x | 18.0x | -4.50 | ELV | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $91.18B | $62.85B | $28.33B | ELV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ELV REV | NTRA REV | ELV GROSS % | NTRA GROSS % | ELV FCF | NTRA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $199.13B | $2.31B | 89.4% | — | $3.17B | $109.1M |
| FY 2024 | $177.01B | $1.70B | 88.8% | — | $4.55B | $69.2M |
| FY 2023 | $171.34B | $1.08B | — | — | $350.7M | -$295.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ELV // BETA 1.07
NTRA // BETA 1.09